A prospective randomized comparative study of the difference in cytopathologic diagnosis between EUS-FNA with or without suction in pancreatic and peripancreatic masses

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000878

Enrollment

Registered

2013-10-08

Start date

2013-06-03

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : For this prospective randomized comparative trial, at least 4 needle passes will be performed in single lesion. The use of suction or non-suction technique in each needle pass will

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pancreatic or peri-pancreatic solid masses who need EUS-FNA for diagnosis

Exclusion criteria

Exclusion criteria: 1) Age 1.5) 4) In use of Thienopyridine (e.g. clopidogrel) 5) Refusal to provide informed consent

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy	—

Secondary

Measure	Time frame
Sample quality (cellularity, number of cells per slide, adequacy of specimen, blood contamination)	—

Countries

Korea, Republic of

Contacts

Public ContactJoon Hyuk Choi

Asan Medical Center

Outcome results